StockpollyBeta
Get App
Popularity #884
WGS · NASDAQ · Medical - Diagnostics & Research

GeneDx (WGS)

Runs exome and genome testing for pediatric and rare-disease diagnosis.

$92.00
After hours+1.26 (+1.39%)
At close$90.74(−7.25%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue53576271779687103117121102114
Cost of revenue282725282929293232423436
Gross profit253137434866587185796878
685651545657636288939496
Research & development141212111212131520242020
434240424345504667747576
Selling & marketing1716161717181819242700
General & administrative2627232626273227444700
Other expenses1120111011−600
Operating income−43−26−14−11−89−59−3−14−26−17
1−1−7−19−1−3−22−4−5−36−1
Interest income100000000000
Interest expense011111111111
Other non-operating income−80618031−244360
Income before tax−42−26−20−29−85−611−7−18−62−18
Income tax expense000000000−111
Net income from continuing operations−42−26−20−29−85−711−8−18−63−19
Other adjustments000000000001
Net income−42−26−20−29−85−711−8−18−63−18
EPS, basic−$1.64−$0.99−$0.78−$1.10−$0.31$0.20−$0.23$0.38−$0.27−$0.61−$2.16−$0.60
EPS, diluted−$1.64−$0.99−$0.78−$1.10−$0.31$0.20−$0.23$0.36−$0.27−$0.59−$2.16−$0.60
Weighted average shares, basic262626272727282929272930
Weighted average shares, diluted262626272727283029272930
EBITDA−26−19−14−23−2120180−11−55−10
Depreciation & amortization965566666777
EBIT−35−25−20−28−86−511−7−18−62−17